[Pharmacological study of a possible dopamine metabolite, tetrahydropapaveroline].
D000470:Alkaloids / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004347:Drug Interactions; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D011346:Prochlorperazine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D000470:Alkaloids; D000928:Antidepressive Agents; D007546:Isoquinolines; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D000661:Amphetamine; D004298:Dopamine; D011346:Prochlorperazine
Etude pharmacologique d'un métabolite présumé de la dopamine, la tétrahydropapavéroline.